AB014. SOH24AB_129. Full cycle audit for using Instillagel mixed with betadine solution per rectum before transrectal ultrasound biopsy for zero urosepsis last 6 months in Nenagh Hospital
Urology Session

AB014. SOH24AB_129. Full cycle audit for using Instillagel mixed with betadine solution per rectum before transrectal ultrasound biopsy for zero urosepsis last 6 months in Nenagh Hospital

Mohamed Zeid, Jamil Malak, Mohammed Abdelrahman, Mustafa Mohammed, Mohammed Osman, Lugman Ahmad, Ahmed Ahmed, Subhasis Giri

Department of Urology & Robotic Surgery, University Hospital Limerick, Dooradoyle, Limerick, Ireland

Background: Transrectal ultrasound (TRUS) biopsy is the gold standard for diagnosing prostate cancer, but it is associated with serious complications such as urosepsis. To avoid this complication, many precautions are taken, including the use of Instillagel before the procedure. The aim is to evaluate the effectiveness of Instillagel mixed with Betadine solution in preventing urosepsis during TRUS biopsy.

Methods: The audit collected data from more than 55 cases that underwent TRUS biopsy in Nenagh Hospital over the last 6 months. The data was analysed to determine the incidence of urosepsis or hospital admission after the procedure.

Results: The audit found zero cases of urosepsis or hospital admission after TRUS biopsy in Nenagh Hospital over the last 6 months. This result is excellent compared to the incidence of urosepsis reported in the literature.

Conclusions: Based on the results of this audit, we believe that Instillagel mixed with Betadine solution is effective in preventing urosepsis and decreasing rectal pain during TRUS biopsy. We recommend the standardization of the technique to ensure its safe and effective use in all TRUS biopsy procedures. Overall, the audit shows that the use of Instillagel mixed with Betadine solution before TRUS biopsy can significantly reduce the incidence of urosepsis and other complications associated with the procedure. This finding is consistent with previous studies that have shown the effectiveness of Instillagel mixed with Betadine solution in reducing the risk of infection during TRUS biopsy. The audit highlights the importance of taking precautions to prevent complications during TRUS biopsy and the need for standardization of the technique to ensure its safe and effective use.

Keywords: Instillagel mixed; transrectal ultrasound biopsy (TRUS biopsy); urosepsis; standardization of the technique; betadine solution

Acknowledgments

Funding: None.

Footnote

Conflicts of Interest: The authors have no conflicts of interest to declare.

Ethical Statement: The authors are accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.

doi: 10.21037/map-24-ab014
Cite this abstract as: Zeid M, Malak J, Abdelrahman M, Mohammed M, Osman M, Ahmad L, Ahmed A, Giri S. AB014. SOH24AB_129. Full cycle audit for using Instillagel mixed with betadine solution per rectum before transrectal ultrasound biopsy for zero urosepsis last 6 months in Nenagh Hospital. Mesentery Peritoneum 2024;8:AB014.

Article Options

Download Citation

Share